Company Filing History:
Years Active: 2019-2022
Title: Matthew G Fury: Innovator in Cancer Treatment
Introduction
Matthew G Fury is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment, particularly in the development of methods for treating skin cancer. With a total of 2 patents to his name, Fury's work is paving the way for innovative therapies.
Latest Patents
Fury's latest patents focus on methods of treating skin cancer by administering a PD-1 inhibitor. The present invention provides methods for treating, reducing the severity, or inhibiting the growth of cancer, specifically skin cancer. The methods involve administering a therapeutically effective amount of a programmed death 1 (PD-1) antagonist, such as an anti-PD-1 antibody. In certain embodiments, the skin cancer targeted includes cutaneous squamous cell carcinoma or basal cell carcinoma.
Career Highlights
Matthew G Fury is currently associated with Regeneron Pharmaceuticals, Inc., where he continues to advance his research in cancer therapies. His work is characterized by a commitment to improving patient outcomes through innovative treatment methods.
Collaborations
Fury collaborates with notable professionals in the field, including his coworker Israel Lowy. Their combined expertise contributes to the ongoing development of effective cancer treatments.
Conclusion
Matthew G Fury is a dedicated inventor whose work in cancer treatment is making a significant impact. His innovative methods for treating skin cancer highlight the importance of research and development in the medical field.